MedTrace Logo

Evaluation of a Gatekeeper Training for Pharmacists

NCT05991635 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 201

Last updated 2024-02-06

No results posted yet for this study

Summary

This study aims to investigate to what extent a gatekeeper training (e-learning) for pharmacists and PTA is effective in changing the attitudes, knowledge, and self-efficacy. Moreover, it aims to examine how they evaluate the training and whether they were able to apply the learned skills in practice.

Conditions

  • Suicide

Interventions

BEHAVIORAL

Gatekeeper training (e-learning)

The gatekeeper training consists of an interactive e-learning (min. 1h, max. 3h) which includes theoretical knowledge, tips, exercises and relevant examples and cases. The main topics included in the e-learning are: * Background information on suicide in Flanders (rates) * Definitions and theoretical background (suicidal process, integrative explanatory model of suicide) * Debunking existing myths about suicide * The role of the pharmacist in suicide prevention * Signal Recognition * Talking about suicide and suicidal thoughts (start the conversation) * How and to whom to refer as pharmacist or FTA * Medication management and medication in the context of suicide * Rights and obligations of a pharmacist/PTA in the context of suicide prevention * Self-care

Sponsors & Collaborators

  • University Ghent

    lead OTHER

Principal Investigators

  • Gwendolyn Portzky, Phd · University Ghent

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-04-12
Primary Completion
2024-01-11
Completion
2024-01-11

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05991635 on ClinicalTrials.gov